These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26892655)

  • 1. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management.
    John AM; Schwartz RA
    J Am Acad Dermatol; 2016 Mar; 74(3):558-66. PubMed ID: 26892655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muir-Torre Syndrome: A Cutaneous Finding Amidst Broader Malignancies.
    Shah RR; Allman P; Schwartz RA
    Am J Clin Dermatol; 2023 May; 24(3):375-380. PubMed ID: 36695997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muir-Torre syndrome.
    Bhaijee F; Brown AS
    Arch Pathol Lab Med; 2014 Dec; 138(12):1685-9. PubMed ID: 25427047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microsatellite instability, immunohistochemistry and mismatch repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre syndrome.
    Ponti G; Manfredini M; Pellacani G; Tomasi A
    Clin Chem Lab Med; 2016 Nov; 54(11):1725-1731. PubMed ID: 27016151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].
    Kacerovská D; Kazakov DV; Cerná K; Hadravský L; Michal M; Dostál J; Skálová A; Michal M
    Cesk Patol; 2010 Oct; 46(4):86-94. PubMed ID: 21313735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome.
    Gaskin BJ; Fernando BS; Sullivan CA; Whitehead K; Sullivan TJ
    Br J Ophthalmol; 2011 Dec; 95(12):1686-90. PubMed ID: 21979897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
    Landis MN; Davis CL; Bellus GA; Wolverton SE
    J Am Acad Dermatol; 2011 Nov; 65(5):1054-1058.e1. PubMed ID: 21550136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Testing of Mismatch Repair Genes Is Needed in the Initial Evaluation of Patients With Muir-Torre Syndrome-Associated Cutaneous Sebaceous Neoplasms: A Case Series.
    Cohen PR; Kurzrock R
    Cureus; 2023 Jan; 15(1):e33975. PubMed ID: 36824550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
    Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
    Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lynch syndrome, Muir Torre variant: 2 cases].
    Castro-Mujica Mdel C; Barletta-Carrillo C; Acosta-Aliaga M; Montenegro-Garreaud X
    Rev Gastroenterol Peru; 2016; 36(1):81-5. PubMed ID: 27131946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muir-Torre syndrome: case report and review of the literature.
    Ang JM; Alai NN; Ritter KR; Machtinger LA
    Cutis; 2011 Mar; 87(3):125-8. PubMed ID: 21488569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch Syndrome and Muir-Torre Syndrome: An update and review on the genetics, epidemiology, and management of two related disorders.
    Le S; Ansari U; Mumtaz A; Malik K; Patel P; Doyle A; Khachemoune A
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
    Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
    Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA mismatch repair system in sebaceous tumors: an update on the genetics and workup of Muir-Torre syndrome.
    Dany M
    Cutis; 2020 Mar; 105(3):E34-E37. PubMed ID: 32352449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muir-Torre syndrome.
    Ponti G; Ponz de Leon M
    Lancet Oncol; 2005 Dec; 6(12):980-7. PubMed ID: 16321766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.
    Harwood CA; Swale VJ; Bataille VA; Quinn AG; Ghali L; Patel SV; Dove-Edwin I; Cerio R; McGregor JM
    J Invest Dermatol; 2001 Feb; 116(2):246-53. PubMed ID: 11180000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.
    Neelakantan IV; Di Palma S; Smith CE; McCoombe A
    Head Neck Pathol; 2016 Sep; 10(3):354-61. PubMed ID: 26577210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Muir-Torre syndrome and Turcot syndrome].
    Velter C; Caussade P; Fricker JP; Cribier B
    Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome.
    Simic D; Dummer R; Freiberger SN; Ramelyte E; Barysch MJ
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.